A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)

PHASE3CompletedINTERVENTIONAL
Enrollment

237

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Clostridium InfectionsDiarrhea
Interventions
DRUG

Rifaximin (Xifaxan)

DRUG

Vancomycin

Trial Locations (63)

10021

Weill Medical College, New York

10595

New York Medical College/Westchester Medical Center, Valhalla

11030

North Shore Hepatology, Manhasset

11212

Brookdale University Hospital and Medical Center, Brooklyn

14642

University of Rochester School of Medicine, Rochester

14905

AMS Clinical Research, Elmira

18103

Lehigh Valley Hospital, Allentown

19107

Drexel University College of Medicine, Philadelphia

19611

RPS Infectious Diseases, West Reading

20037

The George Washington University Medical Center, Washington D.C.

20678

Shah Associates, Prince Frederick

20815

Chevy Chase Clinical Research, Chevy Chase

21201

Baltimore VA Medical Center, Baltimore

University of Maryland, Baltimore

21740

Center for Clinical Research at Washington County Hospital, Hagerstown

24501

Infectious Disease Associates of Central Virginia, Lynchburg

28546

East Carolina Gastroenterology, PA, Jacksonville

28562

Southern Gastroenterology Associates, New Bern

30309

Digestive Healthcare of Georgia, Atlanta

31904

Southeast Regional Research Group, Columbus

32114

Halifax Medical Center, Daytona Beach

32127

Advanced Medical Research Center, Port Orange

32308

Webster Surgical Center LLC, Tallahassee

38801

Digestive Health Specialists, PA, Tupelo

45801

Regional Infectious Diseases - Infusion Center, Lima

45804

Lima Memorial Health System, Lima

48075

Newland Medical Association, Southfield

48202

Henry Ford Hospital, Detroit

48320

Arnold Markowitz, MD, PC, Keego Harbor

53705

Associated Physicians, LLP, Madison

55417

Minneapolis VAMC, Minneapolis

55422

Infectious Disease - Minneapolis Ltd., Minneapolis

55805

St. Mary's/Duluth Clinic Health System, Duluth

55905

Mayo Clinic Rochester, Rochester

59101

Deaconess Billings Clinic Research, Billings

60613

Howard Brown Health Center, Chicago

60637

The University of Chicago, Chicago

61602

Gastroenterology, Ltd., Peoria

61801

Carle Clinic Association NCW5, Urbana

62701

Springfield Clinic, Springfield

62702

Memorial Medical Center, Springfield

66061

GI Specialists, Olathe

66212

Gastrointestinal Associates, Overland Park

66606

Kansas Medical Clinic, Topeka

68114

Infectious Diseases Associates, PC, Omaha

75231

Digestive Disease Associates of Dallas, Dallas

77030

Michael E. DeBakey VA Medical Center, Houston

University of Texas Health Sciences Center, Houston

80501

Gastroenterology of the Rockies, Longmont

83712

Sky Blue, M.D., Boise

85259

Mayo Clinic Scottsdale, Scottsdale

92373

Inland Empire Digestive & Liver Diseases, Redlands

98052

North Pacific Clinical Research, Redmond

06010-0977

Connecticut Gastroenterology Institute, Bristol

50312-5300

Iowa Digestive Disease Center, PC, Des Moines

03756

Dartmouth Hitchcock Medical Center, Lebanon

07024

Drs. Scherl, Chessler, Zingler, Spinnel and Meininger, Fort Lee

07726

Marlboro Gastroenterology PC, Manalapan

07102

St. Michael's Medical Center, Newark

07666

Institute for Clinical Research (ICR) at Holy Name Hospital, Teaneck

08360

The Gastroenterology Group of South Jersey, Vineland

45267-0595

University of Cincinnati, Cincinnati

02905

University Gastroenterology, Providence

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT00269399 - A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) | Biotech Hunter | Biotech Hunter